Biomedical advances are transforming the diagnosis and treatment of disease. Patienthood
is also transforming, as patients actively participate in research, innovation and
regulation of novel technologies and therapies. In this paper we explore the new kinds
of practices that patients are performing in their roles as research subject, co-researchers,
donors, campaigners, representatives and consumers of novel stratified therapies.
We outline their embodied contributions to clinical trials, biobanks and stratified
therapies prior to, during and after having cancer. Exploring how patienthood involves
donating more than tissue or data to these developments, we consider their emotional
and identity work which informs and shapes the novel diagnostics and therapies being
developed. We also consider how this kind of work is stratified according to the social
and biological location of participants, and end by reflecting on the implications
of our analysis for the organisation and regulation of biomedicine.